A. Aurias, C. Rimbaut, D. Buffe, J. M. Zucker, and A. Mazabraud, Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study of four fresh tumors. Cancer genetics and cytogenetics, vol.12, pp.21-26, 1984.

O. Delattre, J. Zucman, and B. Plougastel, Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours, Nature, vol.359, issue.6391, pp.162-167, 1992.

K. Scotlandi, S. Benini, and M. Sarti, Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target, Cancer Res, vol.56, issue.20, pp.4570-4574, 1996.

J. D. Hancock and S. L. Lessnick, A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature, Cell Cycle, vol.7, issue.2, pp.250-256, 2008.

A. Prieur, F. Tirode, P. Cohen, and O. Delattre, EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulinlike growth factor binding protein 3, Mol Cell Biol, vol.24, issue.16, pp.7275-83, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-02438604

D. H. Wai, K. L. Schaefer, and A. Schramm, Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays, International journal of oncology, vol.20, issue.3, pp.441-51, 2002.

C. Siligan, J. Ban, and R. Bachmaier, EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin, Oncogene, vol.24, issue.15, pp.2512-2536, 2005.

M. Kinsey, R. Smith, and S. L. Lessnick, NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma, Mol Cancer Res, vol.4, issue.11, pp.851-860, 2006.

M. Mendiola, J. Carrillo, and E. Garcia, The orphan nuclear receptor DAX1 is upregulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors, International journal of cancer, vol.118, issue.6, pp.1381-1390, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00172274

R. Smith, L. A. Owen, and D. J. Trem, Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma, Cancer cell, vol.9, issue.5, pp.405-421, 2006.

W. Luo, K. Gangwal, S. Sankar, K. M. Boucher, D. Thomas et al., GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance, Oncogene, vol.28, issue.46, pp.4126-4158, 2009.

N. Riggi, M. L. Suva, D. Vito, and C. , EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells, Genes Dev, vol.24, issue.9, pp.916-948, 2010.

D. Olmos, A. S. Martins, R. L. Jones, S. Alam, M. Scurr et al., Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations, Sarcoma, 2011.

K. Baird, S. Davis, and C. R. Antonescu, Gene expression profiling of human sarcomas: insights into sarcoma biology, Cancer research, vol.65, issue.20, pp.9226-9261, 2005.

M. Kauer, J. Ban, and R. Kofler, A molecular function map of Ewing's sarcoma, PLoS ONE, vol.4, issue.4, p.5415, 2009.

T. Melot, N. Gruel, A. Doubeikovski, N. Sevenet, J. L. Teillaud et al., Production and characterization of mouse monoclonal antibodies to wild-type and oncogenic FLI-1 proteins, Hybridoma, vol.16, issue.5, pp.457-64, 1997.

F. Tirode, K. Laud-duval, A. Prieur, B. Delorme, P. Charbord et al., Mesenchymal stem cell features of ewing tumors, Cancer cell, vol.11, issue.5, pp.421-430, 2007.

N. Guillon, F. Tirode, V. Boeva, A. Zynovyev, E. Barillot et al., The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function, PLoS ONE, vol.4, issue.3, p.4932, 2009.

M. Van-de-wetering, I. Oving, and V. Muncan, Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector, EMBO Rep, vol.4, issue.6, pp.609-624, 2003.

L. Dauphinot, D. Oliveira, C. Melot, and T. , Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression, Oncogene, vol.20, issue.25, pp.3258-65, 2001.

D. S. Ft, . Ds, . Ft, . Mb, and . Vp, ZH performed the experiments and analyzed the data. GP and SB were involved in tumors processing and microarrays

B. G. Edd, FR performed in vivo drug experiments. DS, FT and OD wrote the paper